LIVZON PHARMA (01513) spent 8.7832 million yuan on September 24 to repurchase 250,000 shares of A shares.
Lizhu Pharmaceutical (01513) announced that the company invested 8.7832 million yuan on September 24, 2024...
LIVZON PHARMA (01513) announced that the company spent 8.7832 million yuan to repurchase 250,000 A shares on September 24, 2024. The repurchase price was between 34.95 yuan and 35.76 yuan per share.
Related Articles

CIFI HOLD GP (00884) announces annual performance, with shareholders' equity accounting net profit of approximately 17.67 billion yuan, achieving a turnaround from loss to profit.

FULONGMA GROUP (603686.SH) won the bid for three environmental sanitation service projects in March.

WERIDE-W (00800): Kazuhiro Doi resigns as a non-executive director
CIFI HOLD GP (00884) announces annual performance, with shareholders' equity accounting net profit of approximately 17.67 billion yuan, achieving a turnaround from loss to profit.

FULONGMA GROUP (603686.SH) won the bid for three environmental sanitation service projects in March.

WERIDE-W (00800): Kazuhiro Doi resigns as a non-executive director

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


